Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 1
2003 2
2004 3
2005 1
2008 3
2011 3
2012 9
2013 6
2014 6
2015 5
2016 6
2017 6
2018 11
2019 3
2020 6
2021 9
2022 11
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
Medication adherence in schizophrenia.
Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Acosta FJ, et al. Among authors: hernandez jl. World J Psychiatry. 2012 Oct 22;2(5):74-82. doi: 10.5498/wjp.v2.i5.74. World J Psychiatry. 2012. PMID: 24175171 Free PMC article. Review.
Role of rivaroxaban in the prevention of atherosclerotic events.
Sanmartín M, Bellmunt S, Cosín-Sales J, García-Moll X, Riera-Mestre A, Almendro-Delia M, Hernández JL, Lozano F, Mazón P, Suarez Fernández C. Sanmartín M, et al. Among authors: hernandez jl. Expert Rev Clin Pharmacol. 2019 Aug;12(8):771-780. doi: 10.1080/17512433.2019.1637732. Epub 2019 Jul 9. Expert Rev Clin Pharmacol. 2019. PMID: 31269825 Review.
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Among authors: hernandez jl. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586 Free article.
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review.
Herrero-Morant A, Martín-Varillas JL, Castañeda S, Maíz O, Sánchez J, Ortego N, Raya E, Prior-Español Á, Moriano C, Melero-González RB, Graña-Gil J, Urruticoechea-Arana A, Ramos-Calvo Á, Loredo-Martínez M, Salgado-Pérez E, Sivera F, Torre I, Narváez J, Andreu JL, Martínez-González O, Torre RG, Fernández-Aguado S, Romero-Yuste S, González-Mazón Í, Álvarez-Reguera C, Hernández JL, González-Gay MÁ, Blanco R; Neurobehçet Spanish Collaborative Group. Herrero-Morant A, et al. Among authors: hernandez jl. Rheumatology (Oxford). 2022 Nov 2;61(11):4427-4436. doi: 10.1093/rheumatology/keac097. Rheumatology (Oxford). 2022. PMID: 35166821 Review.
Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry.
Coco-Martín MB, Leal-Vega L, Blázquez-Cabrera JA, Navarro A, Moro MJ, Arranz-García F, Amérigo MJ, Sosa-Henríquez M, Vázquez MÁ, Montoya MJ, Díaz-Curiel M, Olmos JM, Ruiz-Mambrilla M, Filgueira-Rubio J, Pérez-Castrillón JL; OSTEOMED Group. Coco-Martín MB, et al. Eur J Clin Pharmacol. 2023 Oct;79(10):1333-1339. doi: 10.1007/s00228-023-03544-x. Epub 2023 Jul 29. Eur J Clin Pharmacol. 2023. PMID: 37515605 Free PMC article.
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition.
González-Juanatey JR, Almendro-Delia M, Cosín-Sales J, Bellmunt-Montoya S, Gómez-Doblas JJ, Riambau V, García-Moll X, García-Alegría J, Hernández JL, Lozano FS, Suarez Fernández C. González-Juanatey JR, et al. Among authors: hernandez jl. Expert Rev Clin Pharmacol. 2020 Jul;13(7):695-706. doi: 10.1080/17512433.2020.1772056. Expert Rev Clin Pharmacol. 2020. PMID: 32434452 Review.
Gabapentin for intractable hiccup.
Hernández JL, Pajarón M, García-Regata O, Jiménez V, González-Macías J, Ramos-Estébanez C. Hernández JL, et al. Am J Med. 2004 Aug 15;117(4):279-81. doi: 10.1016/j.amjmed.2004.03.019. Am J Med. 2004. PMID: 15308440 Review. No abstract available.
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial.
Hernández JL, Lozano FS, Riambau V, Almendro-Delia M, Cosín-Sales J, Bellmunt-Montoya S, Garcia-Alegria J, Garcia-Moll X, Gomez-Doblas JJ, Gonzalez-Juanatey JR, Suarez Fernández C. Hernández JL, et al. Drugs Context. 2020 Jul 6;9:2020-5-5. doi: 10.7573/dic.2020-5-5. eCollection 2020. Drugs Context. 2020. PMID: 32699549 Free PMC article. Review.
88 results